Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Linezolid and Glucose Injection

Approval Number

国药准字H20249784

Company扬子江药业集团上海海尼药业有限公司

Registration Date

December 25, 2024

Drug Information

Generic Name

利奈唑胺葡萄糖注射液

Dosage Form

注射剂

Strength

300ml:利奈唑胺0.6g与葡萄糖15g

Drug Type

化学药品

Registration Date

December 25, 2024

Company Information

Applicant Company

Company Name扬子江药业集团上海海尼药业有限公司

Company Address

浦东新区周浦镇沪南路3999号

Manufacturing Company

Company Name扬子江药业集团上海海尼药业有限公司

Company Address

上海市浦东新区周浦镇沪南路3999号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利奈唑胺葡萄糖注射液 - NMPA 批准文号 | MedPath